TriMix Laboratories announced the launch of TriMix-gel (prostaglandin E, papaverine, phentolamine) for the treatment of erectile dysfunction for patients who cannot tolerate self-injection with a ...
TriMix Laboratories today announced KRS Global Biotechnology has conducted testing on TriMix-gel compounds which allow the expiration date for patient usage to be extended to 60 days. TriMix-gel has ...
CHERRY HILL, N.J., April 30 /PRNewswire/ -- T.J. Harkins, President of TriMix Laboratories LLC, announced today that an abstract related to erectile dysfunction product, TriMix-gel(TM), will be ...
ORLANDO, Fla., June 5 New research presented at the recentAmerican Urological Association Conference by Urologist Joel L. Marmar, M.D.,showed that among men who previously failed to achieve erections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback